Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA consolidated 'Locations' section has been added, listing recruitment sites in Illinois (USA) and in British Columbia, Ontario, and Quebec (Canada). The previous separate 'Locations' subsections and the 'HHS Vulnerability Disclosure' link have been removed.SummaryDifference0.5%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page, indicating a minor metadata update. There are no visible changes to study details or page content.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded related topics 'Ovarian cancer' and 'MedlinePlus Genetics' to the page. Removed a government funding/operating status notice.SummaryDifference0.5%

- Check46 days agoChange DetectedOvarian cancer and related MedlinePlus Genetics topics were removed from the MedlinePlus related topics section.SummaryDifference0.1%

- Check61 days agoChange DetectedLast update timestamp for the study record was refreshed; core study content such as eligibility, treatment arms, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedAdded new MedlinePlus Genetics topic: Ovarian cancer; no deletions.SummaryDifference0.2%

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.